
DT204
CAS No. 428497-71-6
DT204( DT-204 | DT 204 )
Catalog No. M14453 CAS No. 428497-71-6
DT204 (DT-204) is a novel SCFSkp2 inhibitor that reduces Skp2 binding to Cullin-1 and Commd1, synergistically enhances BTZ-induced apoptosis.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 873 | Get Quote |
![]() ![]() |
50MG | 1782 | Get Quote |
![]() ![]() |
100MG | 2250 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameDT204
-
NoteResearch use only, not for human use.
-
Brief DescriptionDT204 (DT-204) is a novel SCFSkp2 inhibitor that reduces Skp2 binding to Cullin-1 and Commd1, synergistically enhances BTZ-induced apoptosis.
-
DescriptionDT204 (DT-204) is a novel SCFSkp2 inhibitor that reduces Skp2 binding to Cullin-1 and Commd1, synergistically enhances BTZ-induced apoptosis; stablizes and increases p27 levels, does not increase the level of p53, demonstrates potential synergy with CI values of 0.7, 0.8 and 0.7 for RPMI8226, U266 and MM1.S respectively combined with 1 nM BTZ, co-treatment induces apoptosis in cells resistant to the proteasome inhibitors BTZ, carfilzomib or ixazomib; overcomes drug resistance and reduces the in vivo growth of myeloma tumors in murine models.
-
In Vitro——
-
In Vivo——
-
SynonymsDT-204 | DT 204
-
PathwayProteasome/Ubiquitin
-
TargetE3 Ubiquitin Ligase
-
RecptorE3 Ubiquitin Ligase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number428497-71-6
-
Formula Weight482.729
-
Molecular FormulaC19H13BrClNO5S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(O)COC1=CC=C(Br)C=C1/C=C(SC(N2CC3=CC=C(Cl)C=C3)=O)/C2=O
-
Chemical Name2-(4-bromo-2-((3-(4-chlorobenzyl)-2,4-dioxothiazolidin-5-ylidene)methyl)phenoxy)acetic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Malek E, et al. Leukemia. 2017 Mar;31(3):645-653.
molnova catalog



related products
-
cIAP1 E3 ligase inhi...
cIAP1 E3 ligase inhibitor D19-14 (cIAP1 inhibitor D19-14) is an improved analog of D19, demonstrates significantly increased ability to inhibit cIAP1 autoubiquitination and reduce protein levels of c-MYC in vitro.
-
NRX-252114
NRX-252114 (NRX 252114, NRX252114) is a potent, small molecule enhancer of β-catenin-β-TrCP interaction, potentiates pSer33/S37A β-catenin binding and ubiquitylation (EC50=6.5 nM).
-
TAME
A small molecule anaphase-promoting complex/cyclosome (APC/C) inhibitor that binds to the APC preferentially suppresses APC/C(Cdc20) rather than APC/C(Cdh1).